These strengths include: family functioning assessment from both patient and clinician perspectives, differential assessment of depressed and manic episodes, the ability to control for symptom status at the time that family functioning was assessed, and a longitudinal, repeated measures design. Continued research on the ways that family functioning and bipolar symptoms mutually influence each other can help identify individuals at highest risk for relapse and increase the ability to use family treatments to create better outcomes for those suffering from bipolar disorder. Article: Miller, I. W. (2006). Family Functioning in Bipolar I Disorder. Journal of Family Psychology, 20(No.
Depression and Cognitive Behavioral Therapy i Depression and Cognitive Behavioral Therapy Your Name Course Information Professor May 2013 Depression and Cognitive Behavioral Therapy i Abstract Depression is a common psychological problem that has both physical and mental symptoms. “Some authorities have estimated that at least 12% of the population have had or will have an episode of depression of sufficient clinical severity to warrant treatment” (Beck, 1979). Some of the features of depression include negative thought processes and loss of concentration or memory. Cognitive Behavior Therapy (CBT) has emerged as one of the most promising treatments for the problem of depression. CBT has many advantages in treating depression, such as helping patients recognize and address negative thoughts.
Numerous professionals within the team are trained in CBT, and use CBT to treat a wide range of issues including self-harm; this is where my interest derives. Through involvement it proved CBT to be efficacious in treating depression and problem solving ability among others thus I have decided to research further into the effectiveness of CBT in the treatment of self-harm. Through research it is evident that self-harming behaviour is frequent among adolescents and young adults and these behaviours are not only challenging on their own but are major risk factors for future suicide (Robinson et al, 2011). “Deliberate self-harm among young people is an important focus of policy and practice internationally. Nonetheless, there is little reliable comparative international information on its extent or characteristics” (Madge et al, 2008:667).
Grilly had found people with Parkinson’s disease (low levels of dopamine) who were taking the drug L-dopa to raise their levels of dopamine were developing schizophrenic type symptoms. There is a flaw with one of the key pieces of evidence to support the dopamine hypothesis. The drugs used to treat schizophrenia by blocking the dopamine receptors can actually increases it as neurons struggle to compensate for the sudden deficiency. Haracz, in a review of post-mortem studies of schizophrenics, found that most of those studied who showed elevated dopamine levels had received antipsychotic drugs shortly before death, unlike post-mortem of schizophrenics who hadn’t received medication these results showed that these individuals had normal levels of dopamine. Therefore, this evidence then in fact weakens the support for the dopamine hypothesis.
Lead researcher Dr. Phillip Shaw said, "If you have a certain variant of this gene, you have a greatly increased risk of having ADHD." In the second study, scientists found that ADHD is associated with lowered dopamine production. ADHD is a real disease, which can not be cured but only treated. According to Journal of Child and Adolescent Psychopharmacrology, scientist recorded a study after conducting research on the long usage of IR-MPH, which they found children who took the 10 month trial of the medicine showed decreased signs of ADHD symptoms. Jeffrey Newcorn’s scholarly journal about Pychopharmacrologic Tretment recognizes methylphenidate and detroamphetamine as both good medicines to help control the symptoms of ADHD.
The results of their findings show that integrated services such as concomitant alcohol and other drug treatment and psychiatric treatment and delivery of various services in a single location, also referred to as ‘one-stop shopping’, improved alcohol and other drug treatment outcomes (Sterling& Weisner, 2006). It is concluded that structural and clinical changes that increase integration between the involved departments, particularly between substance abuse treatment programs and the psychiatry department, could improve outcomes significantly. The results obtained by Sterling & Weisner (2004) have been used to alter the health plan’s practices for alcohol and other drug treatment of adolescents by developing the Dual Diagnosis Best Practices Committee to implement a ‘liaison’ initiative. This initiative places a clinician trained in dual diagnoses in each alcohol and other drug treatment and psychiatry clinic to act as a resource for staff in these clinics (Sterling & Weisner, 2006). The use of research-practice integration models can help to identify research questions that assist in developing new interventions or constellations of services, adapt them to clinical practice, and measure their
After analysis of the three topics, the supporting article, "Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology, and remission rates." by Rothermundt Matthias, and the combative article, "Psychiatric Drugs As Agents Of Trauma." by Charles Whitfield, one can verify which statements are supported to be true, and choose their side. Now the main argument of antidepressants being effective in the long-term treatment of depression vs. the placebo. In the treatment of major depressive disorder there are both arguments saying antidepressants are significantly better than the placebo, and one that say there is little effect using antidepressants compared with the placebo.
Randomized controlled trials suggest DBT is associated with improvement in problem behaviors including suicidal ideations and behaviors, non-suicidal self-injury, and hospitalization. These positive outcomes with adults have prompted use of DBT with adolescents. 1. The major strengths of this study is that numerous randomized controlled trials (RCTs) with adults have demonstrated DBT’s efficacy in treating BPD and a range of other psychiatric disorders across various settings, prompting the use in adolescents with adaptations. 2.
Amanda Suda Mrs. Schmidt Honors English 10 6 March 2013 EMDR and Brainspotting Developed to help patients overcome the symptoms associated with traumatic memories, EMDR and Brainspotting use specific types of focusing and reprocessing to alter the mind. Francine Shapiro, Ph.D., is credited with discovering Eye Movement Desensitization and Reprocessing, or EMDR, in 1989. She found that particular eye movements would reduce the intensity of disturbing thoughts in some of her clients. Since Dr. Shapiro’s discovery, EMDR has been changed and further developed into a highly effective treatment for diseases such as Posttraumatic Stress Disorder (PTSD), Obsessive Compulsive Disorder (OCD), and Panic Disorders. In 2003, David Grand, Ph.D., discovered
Nick Almeida Stephanie Branch Rachel Johnson Intro. Abnormal Psychology Adolescent Schizophrenia Schizophrenia is a serious mental disorder that affects about 1% of the total population. It is characterized by sets of positive and negative symptoms which vary from patient to patient, but in general affects the normal functioning in social and occupational settings. The focus of this paper will be on the causes, diagnoses, and treatments associated with adolescent schizophrenia. It is important to effectively understand adolescent schizophrenia because the disorder can last a lifetime; learning the base causes, the dynamics of a strong diagnosis, and the most effective treatments can greatly improve a patient’s probability